Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Assets Average (2016 - 2025)

Historic Assets Average for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $12.7 million.

  • Nephros' Assets Average rose 1863.54% to $12.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.7 million, marking a year-over-year increase of 1863.54%. This contributed to the annual value of $11.5 million for FY2024, which is 92.3% up from last year.
  • Per Nephros' latest filing, its Assets Average stood at $12.7 million for Q3 2025, which was up 1863.54% from $12.0 million recorded in Q2 2025.
  • Over the past 5 years, Nephros' Assets Average peaked at $18.2 million during Q1 2021, and registered a low of $10.7 million during Q3 2023.
  • Its 5-year average for Assets Average is $13.3 million, with a median of $11.6 million in 2024.
  • As far as peak fluctuations go, Nephros' Assets Average surged by 2179.93% in 2021, and later crashed by 3703.41% in 2022.
  • Nephros' Assets Average (Quarter) stood at $17.7 million in 2021, then tumbled by 37.03% to $11.2 million in 2022, then grew by 2.0% to $11.4 million in 2023, then decreased by 5.2% to $10.8 million in 2024, then rose by 18.03% to $12.7 million in 2025.
  • Its last three reported values are $12.7 million in Q3 2025, $12.0 million for Q2 2025, and $11.5 million during Q1 2025.